Aaron Enke
Sr. Director, Clinical Science, 3B Pharmaceuticals GmbH
Peptide Radiopharmaceutical Panel
Abstract
3B Pharmaceuticals GmbH (3BP) is a German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. As a leader in peptide discovery and optimization, 3BP has built a technology platform extending from hit identification to early clinical development.
The company was founded in 2008 by a team of renowned experts in peptide drug discovery and nuclear medicine from Berlin, Bern and Basel.
Bio
For more than 20 years, Aaron has worked in the biotech and pharmaceutical industry in the clinical evaluation and development of cancer therapeutic and diagnostic agents. Since 2019, Aaron has been working to develop peptide-based radioligand cancer theranostic agents, including Ga-68 and F-18 labeled PET tracers paired with therapeutic agents chelated with ionizing radioligand payloads.